Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis
Status:
Unknown status
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to evaluate the efficacy of Tocilizumab (TCZ) given as
monotherapy in patients with active rheumatoid arthritis (RA) according to EULAR response at
24 weeks after treatment initiation.
The study design is an intervention study, uncontrolled, multicenter, prospective, 32-weeks,
two cohorts of patients with poor compliance or with any contraindication or intolerance to
methotrexate.
One cohort naive to previous biological therapy and the other one treated previously with a
biological treatment.